Our mission is to advance precision medicine for patients with kidney diseases and kidney transplant recipients. We aim to develop and validate liquid biopsy techniques and predictive biomarkers as non-invasive tools, for chronic kidney disease and kidney transplant management, by sharing and assaying biological specimens through a  collaborative effort involving experts from around the world.   The active projects available below demonstrate our unwavering passion to advance research and development.